Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology.

Summary: Top experts have updated the official playbook for treating dementia. The verdict? For standard Alzheimer’s disease, established memory medications (like donepezil and memantine) are still the best tools we have, working well for mild to severe stages. However, popular supplements like Vitamin E, Ginkgo biloba, and statins get a "thumbs down"—they don't treat or prevent the disease.

Crucially, the type of dementia matters. While these drugs help patients with Lewy Body dementia, they do not help with "Mild Cognitive Impairment" (minor memory slips) and can actually cause agitation in patients with Frontotemporal dementia. While we wait for new breakthroughs, accurate diagnosis and targeted medication remain the gold standard.